Trials / Completed
CompletedNCT03813992
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
A Phase III, Dose Ranging, Multi-centre, Randomised, Double Blind, Placebo Controlled, Home Use, Parallel Group Clinical Trial of Topically-applied Glyceryl Trinitrate for the Treatment of Erectile Dysfunction, With an Open Label Extension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,005 (actual)
- Sponsor
- Futura Medical Developments Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the efficacy of various doses of MED2005 versus placebo in male patients with clinically diagnosed erectile dysfunction, and to evaluate the long-term efficacy and safety (12 months) of MED2005.
Detailed description
A phase III, dose-ranging, multi-centre, randomised, double-blind, placebo controlled , home-use, parallel group clinical trial of topically applied glyceryl trinitrate for the treatment of erectile dysfunction with an open label extension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MED2005 | Topical Product |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-07-21
- Completion
- 2020-01-17
- First posted
- 2019-01-23
- Last updated
- 2022-03-02
Locations
53 sites across 9 countries: Bulgaria, Czechia, Georgia, Hungary, Latvia, Poland, Russia, Slovakia, Ukraine
Source: ClinicalTrials.gov record NCT03813992. Inclusion in this directory is not an endorsement.